Sugi Predict

Sugi Predict / Compounds / SCHEMBL1811364

SCHEMBL1811364

SCHEMBL1811364

CC(C)(C)OC(=O)NC1CCN(c2ccc([N+](=O)[O-])c(CS(=O)(=O)c3cccc4ccccc34)c2)CC1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SIRT6 Q8N6T7 1/20 0.41
▸ CKS1B P61024 1/20 0.41
▸ SKP1 P63208 1/20 0.41
▸ SKP2 Q13309 1/20 0.41
▸ SUV39H2 Q9H5I1 3/20 0.40
▸ USP14 P54578 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ DRD2 P14416 3/20 0.38
▸ BRD4 O60885 2/20 0.38
▸ KCNA3 P22001 1/20 0.38
▸ CNR1 P21554 1/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ CCR5 P51681 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1814237 0.95 SUV39H2 (0.41) SIRT6CKS1BSKP1SKP2SUV39H2
SCHEMBL12622493 0.87 CKS1B (0.43) CKS1BSKP1SKP2SUV39H2USP14
SCHEMBL12622483 0.83 SUV39H2 (0.42) SIRT6CKS1BSKP1SKP2SUV39H2
SCHEMBL12655352 0.82 SUV39H2 (0.43) CKS1BSKP1SKP2SUV39H2BRD4
SCHEMBL1814238 0.82 BRD4 (0.43) CKS1BSKP1SKP2SUV39H2ALDH1A1
SCHEMBL3723279 0.81 SIRT6 (0.41) SIRT6MAPTALDH1A1LMNA
SCHEMBL3723277 0.81 SIRT6 (0.41) SIRT6MAPTALDH1A1LMNA
SCHEMBL4284491 0.79 SIRT6 (0.55) SIRT6MAPTALDH1A1DRD2
SCHEMBL14892233 0.76 LMNA (0.53) SIRT6CKS1BSKP1SKP2SUV39H2
SCHEMBL517443 0.76 ALDH1A1 (0.58) SIRT6CKS1BSKP1SKP2SUV39H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7939520-B2 Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands WYETH LLC (US) 2011-05-10 — — US disclosed
US-7939520-B2 Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands WYETH LLC (US) 2011-05-10 — — US disclosed
US-7939520-B2 Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands WYETH LLC (US) 2011-05-10 — — US disclosed
US-20080293688-A1 AMINOAZACYCLYL-3-SULFONYLINDAZOLES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2008-11-27 — — US disclosed
US-20080293688-A1 AMINOAZACYCLYL-3-SULFONYLINDAZOLES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2008-11-27 — — US disclosed
WO-2008144299-A1 5- (AMINOAZACYCLYL) -3-SULFONYL-LH- INDAZOLES AS 5-HYDROXYTRYPTAMINE- 6 LIGANDS FOR THE TREATMENT OF CNS DISORDERS WYETH (US) 2008-11-27 — — WO disclosed
US-20080293688-A1 AMINOAZACYCLYL-3-SULFONYLINDAZOLES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2008-11-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293688-A1 AMINOAZACYCLYL-3-SULFONYLINDAZOLES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS HTR6, HTR3B, HTR5A SIRT6 537/4885CKS1B 4284/4885SKP1 4139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.